Not checked for notices yet.
Targeting the untargetable KRAS in cancer therapy
Pingyu Liu, Yijun Wang, Xin Li
Acta Pharmaceutica Sinica B · 2019
doi:10.1016/j.apsb.2019.03.002
Cited by papers we hold 4
- The path to the clinic: a comprehensive review on direct KRASG12C inhibitors · 2022No notice
- Small molecules in targeted cancer therapy: advances, challenges, and future perspectives · 2021No notice
- Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy · 2021No notice
- Immune modulatory effects of oncogenic KRAS in cancer · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.